 |
|
Users' Guides to the Medical Literature
XVII. How to Use Guidelines and Recommendations About Screening
Alexandra Barratt, MBBS, MPH, PhD;
Les Irwig, MBBCh, PhD;
Paul Glasziou, MBBS, PhD;
Robert G. Cumming, MBBS, MPH, PhD;
Angela Raffle, BSc (Hons), MBChB;
Nicholas Hicks, MA, BMBCh;
J. A. Muir Gray, CBE, MD;
Gordon H. Guyatt, MD, MSc;
for the Evidence-Based Medicine Working Group
JAMA. 1999;281:2029-2034.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
CLINICAL SCENARIO
You are a family physician seeing a 47-year-old woman and her husband of the same age. They are concerned because a friend recently found out that she had bowel cancer and has urged them both to undergo screening with fecal occult blood tests (FOBTs) because, she says, prevention is much better than the cure she is now undergoing. Both your patients have no family history of bowel cancer and no change in bowel habit. They ask whether you agree that they should be screened.
You know that trials of FOBT screening have demonstrated that screening can reduce mortality from colorectal cancer (CRC), but you also . . . [Full Text of this Article]
THE SEARCH
INTRODUCTION
ARE THE RECOMMENDATIONS VALID?
Is There RCT Evidence That Earlier Intervention Works? Were the Data Identified, Selected, and Combined in an Unbiased Fashion?
WHAT ARE THE RECOMMENDATIONS AND WILL THEY HELP YOU IN CARING FOR YOUR PATIENTS?
What Are the Benefits? What Are the Harms? How Do Benefits and Harms Compare in Different People and With Different Screening Strategies? What Is the Impact of People's Values and Preferences? What Is the Impact of Uncertainty Associated With the Evidence? What Is the Cost-effectiveness?
RESOLUTION OF THE SCENARIO
Author Affiliations: Department of Public Health and Community Medicine, University of Sydney, Australia (Drs Barratt, Irwig, and Cumming); Department of Social and Preventive Medicine, University of Queensland, Herston, Australia (Dr Glasziou); Avon Health Authority, Bristol, England (Dr Raffle); Oxfordshire Health Authority, Oxford, England (Dr Hicks); Institute of Health Sciences, University of Oxford, England (Dr Gray); and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario (Dr Guyatt).
RELATED ARTICLE
June 2, 1999
JAMA. 1999;281(21):2057-2058.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Randomized trial of a self-administered decision aid for colorectal cancer screening
Trevena et al.
J Med Screen 2008;15:76-82.
ABSTRACT
| FULL TEXT
Cancer Screening in Renal Transplant Recipients: What Is the Evidence?
Wong et al.
CJASN 2008;3:S87-S100.
ABSTRACT
| FULL TEXT
Accreditation Council for Graduate Medical Education Competencies: Practice-Based Learning and Systems-Based Practice
Moskowitz and Nash
American Journal of Medical Quality 2007;22:351-382.
Technology Assessment in Radiology: Putting the Evidence in Evidence-based Radiology
Hollingworth and Jarvik
Radiology 2007;244:31-38.
ABSTRACT
| FULL TEXT
A clinical screening tool identifies autoimmune diabetes in adults: response to fourlanos et Al.
Davis et al.
Diabetes Care 2006;29:2560-2560.
FULL TEXT
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?
Lord et al.
ANN INTERN MED 2006;144:850-855.
ABSTRACT
| FULL TEXT
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members
Di Napoli et al.
Stroke 2005;36:1316-1329.
ABSTRACT
| FULL TEXT
Searching for Evidence-Based Medicine in the Literature Part 3: Assessment
Bartkowiak
Clin Med Res 2005;3:113-115.
FULL TEXT
Newborn screening information supports public health more than informed choice
Hargreaves et al.
Health Education Journal 2005;64:110-119.
ABSTRACT
Assessing psychosocial/quality of life outcomes in screening: how do we do it better?
McCaffery and Barratt
J. Epidemiol. Community Health 2004;58:968-970.
FULL TEXT
Gaps in the Evidence for Well-Child Care: A Challenge to Our Profession
Moyer and Butler
Pediatrics 2004;114:1511-1521.
ABSTRACT
| FULL TEXT
Use of decision aids to support informed choices about screening
Barratt et al.
BMJ 2004;329:507-510.
FULL TEXT
Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants
Hopley et al.
Br. J. Ophthalmol. 2004;88:450-454.
ABSTRACT
| FULL TEXT
'This added to my multiple myopia'
Irwig
BMJ 2003;326:1336-1336.
FULL TEXT
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson et al.
Circulation 2003;107:499-511.
FULL TEXT
Cancer screening
Barratt et al.
J. Epidemiol. Community Health 2002;56:899-902.
ABSTRACT
| FULL TEXT
Breast self-examination
Baxter
CMAJ 2002;166:166-168.
FULL TEXT
Evidence-based Radiology: A New Approach to the Practice of Radiology
The Evidence-Based Radiology Working Group
Radiology 2001;220:566-575.
ABSTRACT
| FULL TEXT
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter and Covinsky
JAMA 2001;285:2750-2756.
ABSTRACT
| FULL TEXT
Erythropoietin: A Paradigm for the Development of Practice Guidelines
Rizzo et al.
ASH Education Book 2001;2001:10-30.
ABSTRACT
| FULL TEXT
Interpreting, Integrating, and Individualizing Evidence about the Prevention of Diabetic Nephropathy
Cook and Guyatt
ANN INTERN MED 1999;131:707-708.
FULL TEXT
|
